THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle
Bayer stopped the blood thinner drug trial for lack of effect, a major setback. Germany’s Bayer (BAYGn.DE) canceled a significant late-stage experiment testing a...
Notice:
The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to
our Privacy Policy and our Cookie Policy.